GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-07-06: Form 6-K; Period of report 2012-07-06; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201207066k.htm.
- 2012-07-02: Form 6-K; Period of report 2012-07-02; Description GSK CONCLUDES SETTLEMENT WITH US GOVERNMENT; Document gsk201207026k4.htm.
- 2012-07-02: Form 6-K; Period of report 2012-07-02; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201207026k3.htm.
- 2012-07-02: Form 6-K; Period of report 2012-07-02; Description TOTAL VOTING RIGHTS; Document gsk201207026k2.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2012-07-06 | 6-K | 2012-07-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201207066k.htm |
| 2012-07-02 | 6-K | 2012-07-02 | GSK CONCLUDES SETTLEMENT WITH US GOVERNMENT | gsk201207026k4.htm |
| 2012-07-02 | 6-K | 2012-07-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201207026k3.htm |
| 2012-07-02 | 6-K | 2012-07-02 | TOTAL VOTING RIGHTS | gsk201207026k2.htm |
| 2012-07-02 | 6-K | 2012-07-02 | GSK ANNOUNCES PH III DATA FOR LABA/LAMA IN COPD | gsk201207026k.htm |
| 2012-06-29 | 6-K | 2012-06-28 | GSK SETS EXPIRATION OF TENDER OFFER TO ACQUIRE HGS | gsk201206296k.htm |
| 2012-06-28 | 6-K | 2012-06-28 | TRANSACTION IN OWN SHARES | gsk201206286k.htm |
| 2012-06-27 | 6-K | 2012-06-27 | FORM 6-K\ | gsk201206276k.htm |
| 2012-06-26 | 6-K | 2012-06-26 | TRANSACTION IN OWN SHARES | gsk201206266k1.htm |
| 2012-06-26 | 6-K | 2012-06-26 | GSK PUBLISH 2011 CORE OPERATING PROFIT BY SEGMENT | gsk201206266k.htm |
| 2012-06-25 | 6-K | 2012-06-25 | TRANSACTION IN OWN SHARES | gsk201206256k1.htm |
| 2012-06-25 | 6-K | 2012-06-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201206256k.htm |
| 2012-06-22 | 6-K | 2012-06-22 | TRANSACTION IN OWN SHARES | gsk201206226k.htm |
| 2012-06-21 | 6-K | 2012-06-21 | TRANSACTION IN OWN SHARES | gsk201206216k.htm |
| 2012-06-20 | 6-K | 2012-06-20 | TRANSACTION IN OWN SHARES | gsk201206206k.htm |
| 2012-06-19 | 6-K | 2012-06-19 | TRANSACTION IN OWN SHARES | gsk201206196k.htm |
| 2012-06-18 | 6-K | 2012-06-15 | TRANSACTION IN OWN SHARES | gsk201206186k.htm |
| 2012-06-15 | 6-K | 2012-06-15 | TRANSACTION IN OWN SHARES | gsk201206156k1.htm |
| 2012-06-15 | 6-K | 2012-06-15 | GSK CONTINUES WITH TENDER OFFER TO ACQUIRE HGS | gsk201206156k.htm |
| 2012-06-14 | 6-K | 2012-06-14 | TRANSACTION IN OWN SHARES | gsk201206146k2.htm |
| 2012-06-14 | 6-K | 2012-06-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201206146k1.htm |
| 2012-06-14 | 6-K | 2012-06-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201206146k.htm |
| 2012-06-13 | 6-K | 2012-06-13 | TRANSACTION IN OWN SHARES | gsk201206136k.htm |
| 2012-06-12 | 6-K | 2012-06-12 | TRANSACTION IN OWN SHARES | gsk201206126k2.htm |
| 2012-06-12 | 6-K | 2012-06-11 | GSK SIGNS WORLDWIDE ACQUISITION FOR TOCTINO | gsk201206126k.htm |
| 2012-06-11 | 6-K | 2012-06-11 | TRANSACTION IN OWN SHARES | gsk201206116k2.htm |
| 2012-06-11 | 6-K | 2012-06-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201206116k.htm |
| 2012-06-08 | 6-K | 2012-06-08 | TRANSACTION IN OWN SHARES | gsk201206086k2.htm |
| 2012-06-08 | 6-K | 2012-06-08 | GSK EXTENDS TENDER OFFER FOR SHARES OF HGS | gsk201206086k.htm |
| 2012-06-07 | 6-K | 2012-06-07 | TRANSACTION IN OWN SHARES | gsk201206076k.htm |
| 2012-06-06 | 6-K | 2012-06-06 | TRANSACTION IN OWN SHARES | gsk201206066k3.htm |
| 2012-06-06 | 6-K | 2012-06-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201206066k.htm |
| 2012-06-06 | 6-K | 2012-06-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201206066k2.htm |
| 2012-06-01 | 6-K | 2012-06-01 | TRANSACTION IN OWN SHARES | gsk201206016k3.htm |
| 2012-06-01 | 6-K | 2012-05-15 | GSK UPDATE ON TENDER OFFER TO ACQUIRE HGS | gsk201206016k2.htm |
| 2012-06-01 | 6-K | 2012-05-15 | TOTAL VOTING RIGHTS | gsk201206016k.htm |
| 2012-05-31 | 6-K | 2012-05-31 | TRANSACTION IN OWN SHARES | gsk201205316k.htm |
| 2012-05-30 | 6-K | 2012-05-30 | TRANSACTION IN OWN SHARES | gsk201205306k.htm |
| 2012-05-29 | 6-K | 2012-05-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201205296k2.htm |
| 2012-05-29 | 6-K | 2012-05-29 | TRANSACTION IN OWN SHARES | gsk201205296k.htm |
| 2012-05-29 | 6-K | 2012-05-28 | DIRECTOR/PDMR SHAREHOLDING | gsk201205286k.htm |
| 2012-05-29 | 6-K | 2012-05-28 | TRANSACTION IN OWN SHARES | gsk201205286k1.htm |
| 2012-05-25 | 6-K | 2012-05-25 | TRANSACTION IN OWN SHARES | gsk201205256k.htm |
| 2012-05-24 | 6-K | 2012-05-24 | TRANSACTION IN OWN SHARES | gsk201205246k.htm |
| 2012-05-23 | 6-K | 2012-05-23 | TRANSACTION IN OWN SHARES | gsk201205236k2.htm |
| 2012-05-23 | 6-K | 2012-05-23 | GSK AMENDS HGS TENDER OFFER CONDITIONS | gsk201205236k.htm |
| 2012-05-22 | 6-K | 2012-05-22 | TRANSACTION IN OWN SHARES | gsk201205226k.htm |
| 2012-05-21 | 6-K | 2012-05-21 | DIRECTOR/PDMR SHAREHOLDING (REPLACEMENT) | gsk201205216k2.htm |
| 2012-05-21 | 6-K | 2012-05-21 | TRANSACTION IN OWN SHARES | gsk201205216k.htm |
| 2012-05-18 | 6-K | 2012-05-18 | TRANSACTION IN OWN SHARES | gsk201205186k.htm |
| 2012-05-17 | 6-K | 2012-05-15 | GSK STATEMENT ON TENDER OFFER TO ACQUIRE HGS | gsk201205176k1.htm |
| 2012-05-17 | 6-K | 2012-05-15 | TRANSACTION IN OWN SHARES | gsk201205176k.htm |
| 2012-05-16 | 6-K | 2012-05-16 | TRANSACTION IN OWN SHARES | gsk201205166k2.htm |
| 2012-05-16 | 6-K | 2012-05-16 | DIRECTOR DECLARATION | gsk201205166k1.htm |
| 2012-05-16 | 6-K | 2012-05-16 | GSK INCREASES ITS OWNERSHIP IN THERAVANCE | gsk201205166k.htm |
| 2012-05-15 | 6-K | 2012-05-15 | TRANSACTION IN OWN SHARES | gsk201205156k1.htm |
| 2012-05-15 | 6-K | 2012-05-15 | GSK TO FULLY ACQUIRE CELLZOME | gsk201205156k.htm |
| 2012-05-14 | 6-K | 2012-05-14 | TRANSACTION IN OWN SHARES | gsk201205146k.htm |
| 2012-05-11 | 6-K | 2012-05-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201205116k.htm |
| 2012-05-11 | 6-K | 2012-05-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201205116k2.htm |
| 2012-05-11 | 6-K | 2012-05-09 | TRANSACTION IN OWN SHARES | gsk201205116k3.htm |
| 2012-05-11 | 6-K | 2012-05-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201205116k1.htm |
| 2012-05-10 | 6-K | 2012-05-09 | TRANSACTION IN OWN SHARES | gsk201205106k1.htm |
| 2012-05-10 | 6-K | 2012-05-10 | GSK COMMENCES TENDER OFFER TO ACQUIRE HGS | gsk201205106k.htm |
| 2012-05-09 | 6-K | 2012-05-09 | FORM 6-K | d352257d6k.htm |
| 2012-05-09 | 6-K | 2012-05-09 | DOC RE. (AGM STATEMENT) | gsk201205096k3.htm |
| 2012-05-09 | 6-K | 2012-05-09 | BLOCKLISTING INTERIM REVIEW | gsk201205096k2.htm |
| 2012-05-09 | 6-K | 2012-05-09 | TRANSACTION IN OWN SHARES | gsk201205096k1.htm |
| 2012-05-09 | 6-K | 2012-05-09 | GSK TO COMMENCE TENDER OFFER TO ACQUIRE HGS | gsk201205096k.htm |
| 2012-05-08 | 6-K | 2012-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201205086k5.htm |
| 2012-05-08 | 6-K | 2012-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201205086k4.htm |
| 2012-05-08 | 6-K | 2012-05-08 | TRANSACTION IN OWN SHARES | gsk201205086k3.htm |
| 2012-05-08 | 6-K | 2012-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201205086k2.htm |
| 2012-05-08 | 6-K | 2012-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201205086k.htm |
| 2012-05-04 | 6-K | 2012-05-04 | TRANSACTION IN OWN SHARES | gsk201205046k1.htm |
| 2012-05-04 | 6-K | 2012-05-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201205046k.htm |
| 2012-05-03 | 6-K | 2012-05-03 | RESULT OF AGM | gsk201205036k3.htm |
| 2012-05-03 | 6-K | 2012-05-03 | TRANSACTION IN OWN SHARES | gsk201205036k2.htm |
| 2012-05-03 | 6-K | 2012-05-03 | DIRECTOR/PDMR SHAREHOLDING | gsk201205036k1.htm |
| 2012-05-03 | 6-K | 2012-05-02 | DIRECTORATE CHANGE | gsk201205036k.htm |
| 2012-05-02 | 6-K | 2012-02-05 | FORM 6-K | d343895d6k.htm |
| 2012-05-02 | 6-K | 2012-05-02 | FORM 6-K | d343897d6k.htm |
| 2012-05-02 | 6-K | 2012-05-02 | TRANSACTION IN OWN SHARES | gsk201205026k.htm |
| 2012-05-01 | 6-K | 2012-05-01 | TOTAL VOTING RIGHTS | gsk201205016k2.htm |
| 2012-05-01 | 6-K | 2012-05-01 | TRANSACTION IN OWN SHARES | gsk201205016k.htm |
| 2012-04-30 | 6-K | 2012-04-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201204306k2.htm |
| 2012-04-30 | 6-K | 2012-04-30 | TRANSACTION IN OWN SHARES | gsk201204306k1.htm |
| 2012-04-30 | 6-K | 2012-04-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201204306k.htm |
| 2012-04-27 | 6-K | 2012-04-27 | TRANSACTION IN OWN SHARES | gsk201204276k1.htm |
| 2012-04-27 | 6-K | 2012-04-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201204276k.htm |
| 2012-04-26 | 6-K | 2012-04-26 | TRANSACTION IN OWN SHARES | gsk201204266k2.htm |
| 2012-04-26 | 6-K | 2012-04-26 | DIRECTOR/PDMR SHAREHOLDING | gsk201204266k.htm |
| 2012-04-25 | 6-K | 2012-04-25 | 1ST QUARTER RESULTS | gsk201204256k.htm |
| 2012-04-20 | 6-K/A | 2012-04-20 | DIRECTOR/PDMR SHAREHOLDING (REPLACEMENT) | gsk201204206ka5.htm |
| 2012-04-20 | 6-K | 2012-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201204206k4.htm |
| 2012-04-20 | 6-K | 2012-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201204206k2.htm |
| 2012-04-20 | 6-K | 2012-04-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201204206k3.htm |
| 2012-04-20 | 6-K | 2012-04-20 | GSK UPDATE ON DIVESTMENT OF NON-CORE OTC BRANDS | gsk201204206k.htm |
| 2012-04-19 | 6-K | 2012-04-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201204196k2.htm |
| 2012-04-19 | 6-K | 2012-04-19 | GSK CONFIRMS OFFER TO ACQUIRE HGS | gsk201204196k.htm |